hsa-mir-510: Hsa-mir-510 is a miRNA that has been studied in various contexts. In the GSE36791 dataset, the expression levels of hsa-mir-510 showed no statistical difference between samples of subarachnoid hemorrhage (SAH) and normal samples [PMC8768506]. However, hsa-mir-510, along with other RNAs such as JMJD1C-AS1 and LINC01144, was identified as a potential biomarker for predicting SAH [PMC8768506]. In another study, two SNPs (rs5951785 and rs1447393) near hsa-mir-510 were found to be associated with non-obstructive azoospermia (NOA) [PMC5226495]. The expression levels of hsa-mir-510 were significantly down-regulated in mutant types of these SNPs [PMC5226495]. Additionally, overexpression of hsa-mir-510 was associated with improved overall survival in patients with melanoma [PMC8046546]. Hsa-mir-510 has also been implicated in the regulation of serotonin receptor genes in irritable bowel syndrome (IBS) [PMC5561373]. Furthermore, hsa-mir-510 has been found to be present in circulation and can be derived from various tissues of origin [PMC3117799]. Overall, these studies highlight the potential role of hsa-mir-510 as a biomarker and its involvement in various biological processes.